Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KetaMoHydBup: Pharmacokinetic Interaction of S-ketamine, Morphine, Hydromorphone and Buprenorphine

NCT05571176 is registered in ClinicalTrials.gov with Elina Brinck as lead sponsor.

NCT NCT05571176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05571176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KetaMoHydBup: Pharmacokinetic Interaction of S-ketamine, Morphine, Hydromorphone and Buprenorphine
Lead sponsor
Elina Brinck
Phase
Phase 1
Overall status
Unknown status
Start date
January 31, 2023
Completion date
December 31, 2023
Enrollment
12 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

the effect of s-ketamine on pharmacokinetics of morphine, hydromorphone, and buprenorphine